All-natural aggregation-induced emission glycyrrhizic acid active hydrogel as well as preparation method and application thereof
By co-assembling glycyrrhizic acid and berberine derivatives, the AIE glycyrrhizic acid hydrogel was solved, and the mechanical properties and fluorescence characteristics of glycyrrhizic acid hydrogel were achieved, and efficient antibacterial and anti-inflammatory and intelligent fluorescence properties were achieved. It is suitable for biological use Medical materials.
Patent Information
- Application Number
- CN202411137898.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-19
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2044-08-19
AI Technical Summary
The existing glycyrrhizic acid hydrogels have weak mechanical properties, poor functional fluorescence luminescence characteristics, and AIE hydrogels have problems such as poor biocompatibility and complex preparation process.
AIE glycyrrhizic acid hydrogels are prepared by mixing glycyrrhizic acid or its derivatives with berberine derivatives under alkaline conditions, and a natural hydrogel with aggregation-induced luminescence characteristics are formed.
All-natural AIE glycyrrhizic acid hydrogel with excellent mechanical properties, structural recovery characteristics, environmental response fluorescence characteristics, photodynamic antibacterial and anti-inflammatory capabilities was obtained. It is suitable for drug carriers, antibacterial and anti-inflammatory materials and smart fluorescent materials.
Smart Images

Figure CN119033675A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biomedical antibacterial and anti-inflammatory materials and gel materials, and specifically relates to an all-natural aggregation-induced luminescent glycyrrhizic acid active hydrogel and a preparation method and application thereof. Background Art
[0002] Fluorescent hydrogels are a new type of hydrogel that not only has the properties of traditional hydrogels (such as internal gel network structure and certain mechanical strength), but also has certain photoluminescence properties. This type of hydrogel plays an increasingly important role in drug delivery, wound dressings, and tissue engineering. Since the fluorophore will experience aggregation quenching (ACQ) effect in the aggregated state of the gel network, most fluorescent hydrogels currently exhibit weaker fluorescence properties than individual fluorescent substances, which limits the practical application of fluorescent hydrogels. In recent years, the discovery of the aggregation-induced emission (AIE) phenomenon has provided a new idea for the preparation of fluorescent hydrogels with enhanced photoluminescence ability (i.e., AIE hydrogels). AIE hydrogels can be prepared by adding AIE fluorescent molecules to the gel matrix or utilizing their covalent or non-covalent interactions with gel building blocks. In AIE hydrogels, AIE substances are compatible with the semi-solid or condensed state properties of the gel, and the dense gel network structure restricts the intramolecular motion of AIE molecules and inhibits the energy dissipation of AIE molecules through non-radiative transitions, ultimately resulting in the overall hydrogel exhibiting enhanced fluorescence properties. New AIE hydrogels, especially those that can generate reactive oxygen species (ROS) or have high photothermal conversion efficiency after short-term illumination, can exhibit stable and broad-spectrum photodynamic or photothermal antibacterial capabilities, and have attracted much attention in the treatment of bacterial-infected wounds. It is worth noting that to date, most AIE hydrogels are based on semi-synthetic or synthetic AIE substances and hydrogel matrices, which have a series of problems such as high cost, complex synthesis process, poor biocompatibility, and potential toxicity. Therefore, the development of an all-natural and non-toxic AIE hydrogel is crucial to expand its application in food and biomedicine.
[0003] In recent years, the construction of co-assembled supramolecular hydrogels using small molecules, especially natural medicinal and edible small molecules with high bioactivity, biocompatibility and biodegradability, has attracted widespread attention. In order to achieve precise control of the performance of small molecule hydrogels and synergistic enhancement, scientists have begun to use the co-assembly between small molecules to prepare small molecule-small molecule co-assembled hydrogels with various biological applications. Most notably, all-natural AIE hydrogels can be effectively prepared based on the assembly behavior between natural fluorescent small molecules, which has a wide range of potential application value in the fields of antibacterial, anti-inflammatory and wound dressings.
[0004] Glycyrrhizic acid (GA) is a natural triterpenoid saponin with multiple biological activities, and its monomer molecule is composed of hydrophobic aglycone 18β-glycyrrhetinic acid and hydrophilic diglucuronic acid. Saha et al. reported the self-assembly behavior of glycyrrhizic acid in aqueous solution, and found that under the drive of non-covalent bonds, chiral GA molecules showed unique self-assembly characteristics in aqueous solution, first forming long nanofibers with a thickness of 2.5nm, and further assembling into supramolecular hydrogels with three-dimensional network structures (Saha A, Adamcik J, Bolisetty S, et al. Fibrillar networks of glycyrrhizic acid for hydrid nanomaterials with catalytic features [J]. Angewandte Chemie International Edition, 2015, 54 (18): 5408-5412). However, GA hydrogel alone has the disadvantages of weak mechanical properties and single functionality (such as no fluorescence characteristics), which seriously limits its application in the fields of antibacterial and wound dressings. In order to expand the application range of glycyrrhizic acid hydrogel, CN118340934A discloses a method for preparing a self-adhesive glycyrrhizic acid hydrogel and its application, and prepares a self-adhesive glycyrrhizic acid hydrogel by compounding glycyrrhizic acid hydrophilic or water-soluble salts and their modifiers, metal ions, aldehyde polysaccharides and hydrazides, hydroxylamines or primary amine polymer derivatives, and the obtained hydrogel has good biocompatibility, biological functional activity and biodegradability, and promotes the healing of biological tissue wounds. However, the hydrogel components prepared by this patent are complex, and the hydrogel lacks sufficient antibacterial efficacy and unique functionality (such as aggregation-induced luminescence characteristics). Therefore, it is necessary to explore new preparation strategies (such as the assembly behavior between glycyrrhizic acid or its derivatives and other natural small molecules) to construct AIE hydrogels for the development of novel glycyrrhizic acid-based functional hydrogels with actual clinical application value. Summary of the invention
[0005] The purpose of the present invention is to solve the problems of weak mechanical properties, poor functionality (such as fluorescence properties) and limited application of existing glycyrrhizic acid hydrogels, and to solve the problems of poor biocompatibility and complex preparation process of current AIE hydrogels, and to provide a natural aggregation-induced emission (AIE) glycyrrhizic acid active hydrogel. The AIE glycyrrhizic acid active hydrogel is specifically a novel glycyrrhizic acid hydrogel with AIE properties, environmentally responsive fluorescence tunability, high mechanical strength, excellent injectability and structural recovery characteristics, significant traditional and photodynamic antibacterial ability, excellent immunomodulation and anti-inflammatory ability, and promotion of wound healing.
[0006] The purpose of the present invention is achieved through the following technical solutions:
[0007] A method for preparing an all-natural aggregation-induced luminescence glycyrrhizic acid active hydrogel comprises the following steps:
[0008] (1) Dissolving: Dispersing glycyrrhizic acid or its derivatives uniformly in water, stirring at a certain temperature to obtain a transparent solution of glycyrrhizic acid or its derivatives; dispersing a berberine derivative uniformly in water, stirring at a certain temperature until the berberine derivative is completely dissolved to obtain a berberine derivative solution;
[0009] (2) Compounding: adjusting the pH of the glycyrrhizic acid or its derivative solution and the berberine derivative solution obtained in step (1) to neutral with an alkaline pH regulator, and mixing the two in a certain proportion at room temperature to obtain a compound solution;
[0010] (3) Preparation of hydrogel: The composite solution obtained in step (2) is adjusted to acidic pH using an acidic pH regulator under continuous stirring, and stirred until a natural AIE glycyrrhizic acid hydrogel is obtained.
[0011] Preferably, in step (1), the glycyrrhizic acid or its derivatives include one of glycyrrhizic acid, ammonium glycyrrhizinate, ammonium glycyrrhizinate, monopotassium glycyrrhizinate, dipotassium glycyrrhizinate, and trisodium glycyrrhizinate.
[0012] Preferably, in step (1), the berberine derivative includes one of berberine hydrochloride hydrate, berberine chloride hydrate, berberine extract, berberine sulfate hydrate, berberine hydrogen sulfate, and berberine tannate.
[0013] Preferably, in step (1), the stirring temperature is 60-90° C., the stirring speed is 100-500 rpm, and the stirring time is 5-15 min.
[0014] Preferably, in step (1), the concentration of the glycyrrhizic acid or its derivative solution is 2%-6%; the concentration of the berberine derivative solution is 0.5%-2%.
[0015] Preferably, in step (2), the alkaline pH regulator is one of sodium hydroxide solution, potassium hydroxide solution, disodium hydrogen phosphate solution, and sodium bicarbonate; the concentration of the alkaline pH regulator is 0.5-4 mM, and the pH of the glycyrrhizic acid or its derivative solution and the berberine derivative solution is adjusted to 6.0-8.0.
[0016] Preferably, in step (2), the combined concentration ratio of the glycyrrhizic acid or its derivative solution to the berberine derivative solution is 1000:1-4:1.
[0017] Preferably, in step (2), the concentration of the glycyrrhizic acid or its derivative solution in the composite solution is 0.1%-1%.
[0018] Preferably, in step (2), the concentration of the berberine derivative solution in the composite solution is 0.001%-0.25%.
[0019] Preferably, in step (3), the stirring speed is 400-1000 rpm and the stirring time is 2-10 min.
[0020] Preferably, in step (3), the acidic pH regulator includes one of hydrochloric acid, sulfuric acid, citric acid, tartaric acid, acetic acid, and gluconolactone, and the concentration of the acidic pH regulator is 0.5-2mM, and the pH of the composite solution is adjusted to 3.0-5.0.
[0021] The invention provides a preparation method for preparing a fully natural aggregation-induced luminescence glycyrrhizic acid active hydrogel.
[0022] Preferably, the all-natural aggregation-induced luminescence glycyrrhizic acid active hydrogel is a glycyrrhizic acid hydrogel having aggregation-induced luminescence properties, excellent mechanical and structural recovery properties, environmentally responsive fluorescence properties, photodynamic antibacterial, anti-inflammatory and other functional properties.
[0023] The all-natural aggregation-induced luminescence glycyrrhizic acid active hydrogel dressing provided by the present invention can be applied to the fields of drug carriers, antibacterial and anti-inflammatory materials, smart fluorescent materials or medical gel dressings.
[0024] Compared with the prior art, the present invention has the following advantages and beneficial technical effects:
[0025] 1. The present invention cleverly utilizes the interaction between natural medicine and food, glycyrrhizic acid or its derivatives and berberine derivatives to co-assemble and construct a new type of aggregation-induced luminescence functional glycyrrhizic acid hydrogel. The inventors found that berberine molecules, which originally only showed AIE effects in organic solvents but had no AIE properties in aqueous solutions, can be co-assembled to form an assembly and a hydrogel by compounding glycyrrhizic acid or its derivatives with berberine derivatives and utilizing the interaction between the two. The formation of the assembly can effectively prevent the movement of berberine molecules, prompting them to release energy in the form of radiation transition (light energy), and ultimately endow the hydrogel with excellent AIE properties.
[0026] 2. The raw materials used in the present invention are all small molecules of natural origin that are both medicinal and edible, non-toxic and harmless, and have good biocompatibility and a wide range of pharmacological activities.
[0027] 3. The preparation method of the present invention has a simple system, rapid reaction, and does not require the addition of auxiliary gelling factors. The hydrogel can be formed by the co-assembly behavior of small molecules. Specifically, the AIE glycyrrhizic acid hydrogel is prepared by mixing glycyrrhizic acid or its derivatives with berberine derivatives under alkaline conditions and using pH adjustment technology. In the process of regulating the pH of the system, glycyrrhizic acid molecules can assemble to form glycyrrhizic acid fibers, and at the same time form an assembly through electrostatic interaction with berberine molecules. The fiber network and assembly in the system effectively prevent the movement of berberine molecules, prompting them to dissipate energy in the form of radiation transition (light energy), and finally form an AIE hydrogel.
[0028] 4. The hydrogel of the present invention exhibits unique aggregation-induced luminescence properties. Compared with the hydrogel of glycyrrhizic acid or its derivatives or the berberine aqueous solution alone, the hydrogel prepared by the present invention has stronger photoluminescence properties.
[0029] 5. The AIE hydrogel of the present invention has excellent injectability and structural recovery characteristics, temperature and pH responsive fluorescence properties, and has great application prospects in biomedical intelligent fluorescent materials.
[0030] 6. The hydrogel of the present invention exhibits sufficient mechanical properties and strong intrinsic biological activity. Compared with the hydrogel of glycyrrhizic acid or its derivatives or the aqueous solution of berberine derivatives alone, the hydrogel prepared by the present invention exhibits more excellent antibacterial and anti-inflammatory effects, especially it can achieve photodynamic synergistic antibacterial and sterilization, further improving the antibacterial and anti-inflammatory ability of the hydrogel.
[0031] 7. The hydrogel of the present invention has good biocompatibility, is easily degradable, and has no cytotoxicity, and can be widely used in the field of biomedical materials.
[0032] 8. The AIE hydrogel in the present invention can be covered on the wound surface, reducing the risk of infection during wound healing and increasing the healing rate of infected wounds, thus playing a practical application and commercial value in the field of medical gel dressings. BRIEF DESCRIPTION OF THE DRAWINGS
[0033] Figure 1 This is the appearance of the hydrogels of Comparative Examples 1 and 2 and Examples 2 and 3 of the present invention.
[0034] Figure 2 This is the fluorescence emission spectrum of the AIE glycyrrhizic acid hydrogel in Example 1 of the present invention.
[0035] Figure 3 It is the fluorescence emission spectrum of the berberine derivative solution of comparative example 3 in the present invention.
[0036] Figure 4 Graph showing the fluorescence emission spectra of the glycyrrhizic acid hydrogel alone of Comparative Example 1 and the AIE glycyrrhizic acid hydrogel of Example 2 of the present invention.
[0037] Figure 5 It is the frequency scanning diagram of the glycyrrhizic acid hydrogel alone of Comparative Example 2 and the AIE glycyrrhizic acid hydrogel of Example 3 in the present invention.
[0038] Figure 6 1 and 2 are the viscosity curves of the glycyrrhizic acid hydrogel alone of Comparative Example 2 and the AIE glycyrrhizic acid hydrogel of Example 3 of the present invention.
[0039] Figure 7 This is the thixotropic recovery curve of the AIE glycyrrhizic acid hydrogel of Example 3 of the present invention.
[0040] Figure 8 This is a fluorescence emission spectrum of the AIE glycyrrhizic acid hydrogel in Example 4 of the present invention during the pH reduction process.
[0041] Fig. 9 This is a graph showing the fluorescence intensity change of the AIE glycyrrhizic acid hydrogel of Example 5 of the present invention during the cyclic heating-cooling process.
[0042] Fig.10 The bacterial survival rate is obtained by conducting an antibacterial test on Staphylococcus aureus by the glycyrrhizic acid hydrogel of Comparative Example 2 and the AIE glycyrrhizic acid hydrogel of Example 3 in the present invention.
[0043] Fig.11 The figure shows the effects of the glycyrrhizic acid hydrogel of Comparative Example 2 and the AIE glycyrrhizic acid hydrogel of Example 3 on the level of TNF-α inflammatory factor.
[0044] Fig.12 The figure is a graph showing the changes in wound area of wounds infected with drug-resistant Staphylococcus aureus (MRSA) treated with different hydrogels according to the present invention. DETAILED DESCRIPTION
[0045] In order to better understand the present invention, the present invention is further described below in conjunction with the accompanying drawings and embodiments, but the embodiments of the present invention are not limited thereto.
[0046] Example 1
[0047] A fully natural aggregation-induced luminescence active glycyrrhizic acid active hydrogel, the preparation method of which comprises the following steps:
[0048] (1) Add ammonium glycyrrhizinate powder to deionized water, stir at a stirring speed of 100 rpm and a temperature of 90° C. for 5 min, until a clear and transparent ammonium glycyrrhizinate solution (6%) is obtained. At the same time, berberine hydrochloride hydrate is uniformly dispersed in water, stirred at 90° C. and a stirring speed of 200 rpm for 5 min, and a completely dissolved berberine hydrochloride hydrate solution (2%) is obtained.
[0049] (2) adjusting the pH of the ammonium glycyrrhizic acid solution and the berberine hydrochloride hydrate solution obtained in step (1) to about 7.0 with potassium hydroxide (1 mM), and then mixing the ammonium glycyrrhizic acid solution and the berberine hydrochloride hydrate solution at 25° C. in a concentration ratio of 100:1, 50:1, 25:1, and 10:1, so that the concentration of the ammonium glycyrrhizic acid solution in the system is 0.1%, 0.25%, 0.5%, and 1%, and the concentration of the berberine solution is 0.01%.
[0050] (3) The composite solution containing different concentrations of ammonium glycyrrhizinate solution obtained in step (2) was stirred at 1000 rpm, and the pH of all samples was adjusted to 4.0 using 0.5 mM hydrochloric acid. After stirring for 2 min, the natural AIE glycyrrhizic acid hydrogels were obtained by standing, which were respectively recorded as hydrogel 1, hydrogel 2, hydrogel 3, and hydrogel 4.
[0051] Example 2
[0052] A fully natural aggregation-induced luminescence glycyrrhizic acid active hydrogel, the preparation method of which comprises the following steps:
[0053] (1) Add dipotassium glycyrrhizinate powder to deionized water, stir at a stirring speed of 500 rpm and a temperature of 60° C. for 15 min, until a clear and transparent dipotassium glycyrrhizinate solution (2%) is obtained. At the same time, berberine sulfate hydrate is uniformly dispersed in deionized water, stirred at 60° C. and a stirring speed of 500 rpm for 15 min, and a completely dissolved berberine sulfate hydrate solution (0.5%) is obtained.
[0054] (2) The pH of the dipotassium glycyrrhizic acid solution and the berberine sulfate hydrate solution obtained in step (1) was adjusted to about 6.0 with disodium hydrogen phosphate (1 mM), and then the dipotassium glycyrrhizic acid solution and the berberine sulfate hydrate solution were mixed at 25° C. in a concentration ratio of 1000:1, 500:1, 200:1, and 100:1, so that the concentration of the dipotassium glycyrrhizic acid solution in the system was 1%, and the concentration of the berberine sulfate hydrate solution was 0.001%, 0.0025%, 0.05%, and 0.01%.
[0055] (3) The composite solution containing different concentrations of sulfated berberine hydrate solution obtained in step (2) was stirred at 400 rpm, and the pH of all samples was adjusted to 3.5 using 0.5 mM hydrochloric acid. After stirring for 10 min, the natural AIE glycyrrhizic acid hydrogels were obtained by standing, which were respectively recorded as hydrogel 5, hydrogel 6, hydrogel 7, and hydrogel 8.
[0056] Example 3
[0057] A fully natural aggregation-induced luminescence glycyrrhizic acid active hydrogel, the preparation method of which comprises the following steps:
[0058] (1) Add ammonium glycyrrhizinate powder to deionized water, stir at a stirring speed of 200 rpm and a temperature of 80° C. for 10 min, until a clear and transparent ammonium glycyrrhizinate solution (2%) is obtained. At the same time, berberine sulfate hydrate is uniformly dispersed in deionized water, stirred at 80° C. and a stirring speed of 200 rpm for 10 min, and a completely dissolved berberine sulfate hydrate solution (2%) is obtained.
[0059] (2) adjusting the pH of the ammonium glycyrrhizic acid solution obtained in step (1) to about 8.0 with sodium hydroxide (4 mM), and then mixing the ammonium glycyrrhizic acid solution and the sulfated berberine hydrate solution at 25° C. in a concentration ratio of 100:1, 40:1, 20:1, 10:1, and 4:1, so that the concentration of the ammonium glycyrrhizic acid solution in the system is 1%, and the concentration of the sulfated berberine hydrate solution is 0.01%, 0.025%, 0.05%, 0.1%, and 0.25%.
[0060] (3) The composite solution containing different concentrations of sulfated berberine hydrate solution obtained in step (2) was stirred at 1000 rpm, and the pH of all samples was adjusted to 4.5 using 0.5 mM hydrochloric acid. After stirring for 3 min, the natural AIE glycyrrhizic acid hydrogels were obtained by standing, which were respectively recorded as hydrogel 9, hydrogel 10, hydrogel 11, hydrogel 12, and hydrogel 13.
[0061] Example 4
[0062] A fully natural aggregation-induced luminescence glycyrrhizic acid active hydrogel, the preparation method of which comprises the following steps:
[0063] (1) Add ammonium glycyrrhizinate powder to deionized water, stir at a stirring speed of 400 rpm and a temperature of 70° C. for 10 min, until a clear and transparent ammonium glycyrrhizinate solution (2%) is obtained. At the same time, berberine sulfate hydrate is uniformly dispersed in deionized water, stirred at 70° C. and a stirring speed of 200 rpm for 10 min, and a completely dissolved berberine sulfate hydrate solution (2%) is obtained.
[0064] (2) adjusting the pH of the ammonium glycyrrhizic acid solution and the berberine sulfate hydrate solution obtained in step (1) to about 7.0 with sodium hydroxide (0.5 mM), and then mixing the ammonium glycyrrhizic acid solution and the berberine sulfate hydrate solution at a concentration ratio of 100:1 at 25° C., so that the concentration of the ammonium glycyrrhizic acid solution in the system is 1% and the concentration of the berberine sulfate hydrate solution is 0.01%.
[0065] (3) The composite solution obtained in step (2) was stirred at 1000 rpm, and gluconolactone was added to slowly adjust the pH of the sample to 4.5. After stirring for 5 minutes, the mixture was allowed to stand to obtain an AIE glycyrrhizic acid hydrogel, wherein the concentration of gluconolactone in the system was 0.5 mM.
[0066] Example 5
[0067] A fully natural aggregation-induced luminescence glycyrrhizic acid active hydrogel, the preparation method of which comprises the following steps:
[0068] (1) Glycyrrhizic acid powder was added to deionized water, and stirred at a stirring speed of 300 rpm and a temperature of 80° C. for 10 min until a clear and transparent glycyrrhizic acid solution (2%) was obtained. At the same time, berberine chloride hydrate was uniformly dispersed in deionized water, and stirred at 80° C. and a stirring speed of 300 rpm for 10 min to obtain a completely dissolved berberine chloride hydrate solution (2%).
[0069] (2) The pH of the glycyrrhizic acid solution and the berberine chloride hydrate solution obtained in step (1) was adjusted to about 7.0 with sodium hydroxide (0.5 mM), and then the two were mixed at a concentration ratio of 20:1 at 25° C., so that the concentration of the glycyrrhizic acid solution in the system was 1% and the concentration of the berberine chloride hydrate solution was 0.05%.
[0070] (3) The composite solution obtained in step (2) was stirred at 1000 rpm, citric acid (0.5 mM) was added to slowly adjust the pH of the sample to 3.5, and the mixture was stirred for 3 min and then allowed to stand to obtain the AIE glycyrrhizic acid hydrogel.
[0071] Comparative Example 1
[0072] A dipotassium glycyrrhizinate supramolecular hydrogel, the preparation method of which comprises the following steps:
[0073] Dipotassium glycyrrhizinate powder was added to deionized water, stirred at 60°C and 200 rpm for 15 min until a clear and transparent dipotassium glycyrrhizinate solution (1%) was obtained. After cooling at room temperature, dipotassium glycyrrhizinate supramolecular hydrogel was obtained, which was named comparative hydrogel 1.
[0074] Comparative Example 2
[0075] An ammonium glycyrrhizinate supramolecular hydrogel, the preparation method of which comprises the following steps:
[0076] Ammonium glycyrrhizinate powder was added to deionized water and stirred at 80°C and 200 rpm for 10 min until a clear and transparent ammonium glycyrrhizinate solution (1%) was obtained. After cooling at room temperature, an ammonium glycyrrhizinate supramolecular hydrogel was obtained, which was named comparative hydrogel 2.
[0077] Comparative Example 3
[0078] A berberine derivative solution, the preparation method of which comprises the following steps:
[0079] The berberine hydrochloride hydrate was uniformly dispersed in water, stirred at 90°C and 200 rpm for 5 min to obtain a completely dissolved berberine hydrochloride hydrate solution (2%), which was diluted with deionized water to a concentration of 0.01%. Thereafter, the pH of the berberine hydrochloride hydrate solution was adjusted to about 7.0 with sodium hydroxide (1 mM), and the final solution was recorded as comparative solution 1.
[0080] Performance Test:
[0081] (1) Fluorescence intensity test of AIE glycyrrhizic acid hydrogel
[0082] The fluorescence emission spectrum of the hydrogel was tested using a fluorescence spectrophotometer (F-7100, Hitachi, Japan), with the excitation wavelength selected as 405 nm, the emission wavelength range set to 450-700 nm, and the slit width of the emission spectrum set to 2.5 nm. Pure glycyrrhizic acid hydrogel and berberine solution were used as controls in the experiment.
[0083] (2) Rheological frequency scanning test of AIE glycyrrhizic acid hydrogel
[0084] Use HAKKE MARS 60 rheometer to perform frequency sweep test on hydrogel (frequency range is 0.1-10Hz). Place the hydrogel on the sample stage of the rheometer, and select parallel plates with a diameter of 35mm for testing. The gap between the sample stage and the parallel plate is 1mm. Frequency sweep test conditions: fix the test stress value (0.1%, within the linear range of modulus), set the frequency range to 0.1-10Hz, and record the trend of elastic modulus (G') and viscous modulus (G") with frequency.
[0085] Examples 1-3 are a series of AIE glycyrrhizic acid hydrogels prepared by different preparation processes (such as different derivative types and different component concentrations). Examples 1-3 prepare AIE hydrogels with semi-solid properties by compounding glycyrrhizic acid or its derivatives and berberine derivatives. Figure 1 As shown in the figure, compared with the hydrogel appearance of Comparative Examples 1 and 2, the hydrogels formed in Examples 2 and 3 prepared under the same conditions have stronger three-dimensional formability and can emit bright green fluorescence under ultraviolet light (Comparative Examples 1 and 2 cannot emit bright green fluorescence), which shows that the hydrogels prepared in Examples 2 and 3 of the present invention can effectively improve the weak formability of the single glycyrrhizic acid supramolecular hydrogel and give the hydrogel new fluorescent luminescence properties. The fluorescence emission spectra of the hydrogel prepared in Example 1 and the single berberine solution of Comparative Example 3 are shown as follows: Figure 2 and Figure 3 As shown, it can be seen that compared with the 0.01% berberine solution alone in Comparative Example 3 ( Figure 3 ), all hydrogel systems in Example 1 showed significantly higher fluorescence intensity, and the fluorescence intensity of these hydrogels increased significantly as the concentration of glycyrrhizic acid derivatives in the system increased from 0.1% to 1%. In addition, Figure 4 The fluorescence spectra of the AIE glycyrrhizic acid hydrogel of Example 2 and the pure glycyrrhizic acid hydrogel of Comparative Example 1 are shown. It can be seen that the increase in the concentration of berberine derivatives can effectively improve the fluorescence intensity of the hydrogel. These data together confirm that the fluorescent hydrogel co-assembled by glycyrrhizic acid or its derivatives and berberine derivatives has significant aggregation-induced emission properties, and a stronger AIE effect can be achieved by increasing the concentration of glycyrrhizic acid or its derivatives or berberine derivatives in the system.
[0086] The rheological frequency scanning curve of the AIE glycyrrhizic acid hydrogel prepared in Example 3 is as follows: Figure 5 As shown (solid graph represents elastic modulus G', hollow graph represents viscous modulus G"), it can be seen from the figure that G' of the hydrogel is greater than G", further proving the formation of the hydrogel and their semi-solid viscoelastic properties. Compared with Comparative Example 2, the hydrogel prepared in Example 3 has larger elastic modulus and viscous modulus values, indicating that the mechanical strength of the hydrogel can be significantly enhanced by increasing the content of berberine derivatives in the hydrogel.
[0087] (3) Viscosity test of AIE glycyrrhizic acid hydrogel
[0088] The hydrogel was placed on the sample stage of the rheometer, with a gap of 1 mm between the sample stage and the parallel plate (diameter 35 mm). The hydrogel was measured at a shear rate of 0.01-100 s using a HAKKE MARS 60 rheometer. -1 The viscosity curve below.
[0089] (4) Thixotropic recovery test of AIE glycyrrhizic acid hydrogel
[0090] The thixotropic recovery properties of the hydrogel were tested using a HAKKE MARS 60 rheometer. The specific operation was as follows: the hydrogel was placed on the sample stage of the rheometer, and the gap between the sample stage and the parallel plate (35 mm in diameter) was 1 mm. The thixotropic recovery test conditions were: the changes in G′ and G″ over time were measured under alternating low strains (0.1%, within the LVR) and high strains (10%, beyond the LVR).
[0091] Taking the hydrogel obtained in Example 3 as an example, its viscosity curve was tested. Figure 6 The viscosity curve of the hydrogel obtained in Example 3 is shown by Figure 6It can be seen from the data that the viscosity of the hydrogel decreases with the increase of shear rate, showing typical shear thinning behavior. Shear thinning behavior is a classic feature of injectable materials, which also confirms from the side that the AIE hydrogel prepared by the present invention has excellent injectability and provides the ability of the hydrogel to cover various irregular skin wounds. The AIE hydrogel prepared in Example 3 was further subjected to alternating strains (0.1%, 10% and 0.1%), and the changes in its elastic modulus (G') and viscous modulus (G") were observed to explore the structural recovery ability of these hydrogels. Figure 7 From the thixotropic recovery test results shown (solid graphs represent G', hollow graphs represent G"), it can be seen that the elastic modulus and viscous modulus of the AIE hydrogel obtained in Example 3 can still be largely restored to the initial state after the cycle of small strain (0.1%)-large strain (10%)-small strain (0.1%), indicating that the AIE hydrogel co-assembled by the two medicinal and edible homologous molecules has excellent structural recovery ability. The ideal mechanical strength and excellent structural recovery performance of the AIE hydrogel can make it possible for it to be attached to the wound as an ideal dressing and quickly heal itself.
[0092] (5) pH-responsive fluorescence test of hydrogel
[0093] In the study of pH-responsive fluorescence properties, as shown in Example 4, glucono-δ-lactone needs to be added to the composite solution to slowly lower the pH value. During the pH lowering process, a fluorescence spectrophotometer is used to measure the change in fluorescence intensity of the hydrogel system at an emission wavelength of 545.5 nm.
[0094] Figure 8 The fluorescence emission spectrum of the measured AIE hydrogel during the pH reduction process. As can be seen from the figure, as the pH slowly decreases, the fluorescence intensity of the hydrogel gradually increases. During the pH reduction process, the glycyrrhizic acid network is more tightly stacked and entangled, which further increases the aggregation of the hydrogel, hinders the movement of berberine molecules, and prompts it to release more energy through non-radiative transitions, emitting brighter fluorescence and showing stronger fluorescence intensity.
[0095] (6) Temperature responsive fluorescence test of hydrogel
[0096] In the temperature-responsive fluorescence test, the temperature of the hydrogel in Example 5 was adjusted to the corresponding temperature (25°C and 80°C). The hydrogel was first gradually heated from 25°C to 80°C, and then cooled to 25°C. This heating-cooling cycle was repeated five times, and the changes in the fluorescence intensity (emission wavelength 545.5 nm) of the hydrogel at 25°C and 80°C were measured during this process.
[0097] Taking the hydrogel prepared in Example 5 as an example, the temperature-responsive fluorescence properties of the hydrogel were investigated. Fig. 9 Figure 3 is the fluorescence intensity diagram of the hydrogel at 25°C and 80°C during the cyclic heating-cooling process. It can be seen from the figure that during the five cycles of heating (80°C)-cooling (25°C), the hydrogel always shows a relatively higher fluorescence intensity at 25°C. Once the temperature rises to 80°C, the fluorescence intensity of the hydrogel decreases again, indicating that the hydrogel has temperature-controllable AIE behavior.
[0098] (7) Antibacterial experiment of AIE glycyrrhizic acid active hydrogel
[0099] The bactericidal ability of the hydrogel of the present invention was evaluated by observing the colony on a plate, and Staphylococcus aureus was used as a representative. After the deionized water was treated by a membrane (0.22 μm water system membrane), sterile water was obtained. The deionized water in Example 3 was replaced with the prepared sterile water, and the hydrogel was prepared according to the method of Example 3. The hydrogel was irradiated under ultraviolet light for 30 minutes to obtain a sterile hydrogel. First, the bacterial suspension was diluted several times with a sterile PBS solution to obtain the OD of the final bacterial suspension. 600 The value is close to 0.65. Subsequently, 100 μL of the obtained bacterial suspension was added to the surface of the AIE glycyrrhizic acid hydrogel (0.2 g). Next, the samples with bacteria added were divided into a dark group, a 30-min illumination group, and a 60-min illumination group. Among them, the dark group was incubated in the dark at 37°C for 4 hours, and the 30-min illumination group and the 60-min illumination group first exposed the samples containing bacteria to white light (20 mW / cm 2 ) for 30 and 60 min respectively, and then they were placed in the dark for an additional incubation time (total time was 4 h). Finally, 100 μL of the bacterial suspension was spread on an agar plate and incubated at 37 °C for 24 h. The number of bacteria was recorded and the bacterial survival rate was calculated.
[0100] Fig.10 This is an evaluation test of the antibacterial ability of the AIE glycyrrhizic acid hydrogel prepared according to the method of Example 3 of the present invention against Staphylococcus aureus. The results show that compared with the control (PBS treatment) and the glycyrrhizic acid hydrogel alone (comparative hydrogel 2), the bacterial survival rate treated with the AIE hydrogel was significantly reduced, and this phenomenon became more obvious with the increase in the concentration of berberine derivatives, indicating that the AIE glycyrrhizic acid hydrogel has excellent antibacterial and bactericidal ability. It is worth noting that compared with the blank samples of the dark hydrogel group and the corresponding illumination group, the hydrogel group treated with light, i.e., the AIE glycyrrhizic acid hydrogel illumination 30min and illumination 60min groups, all showed lower bacterial survival rates, which indicates that the aggregation-induced luminescence glycyrrhizic acid hydrogel has the ability of photodynamic antibacterial, which can further improve the antibacterial effect on the antibacterial ability of the hydrogel itself.
[0101] (8) In vitro anti-inflammatory experiment of AIE glycyrrhizic acid active hydrogel
[0102] The in vitro anti-inflammatory ability of the hydrogel was evaluated using the lipopolysaccharide (LPS) cell inflammation model. RAW264.7 macrophages seeded in a 96-well plate were cultured at 37°C and 5% CO2 for 24 hours, and LPS (100 μL, 1 μg / mL) was added to induce cell inflammatory response, and then incubated for another 24 hours. After that, fresh DMEM medium containing the hydrogel extract was added to the cells and cultured for 24 hours, and finally the level of pro-inflammatory factors (TNF-α) in the supernatant was detected using an enzyme-linked immunosorbent assay (ELISA) kit.
[0103] The anti-inflammatory ability of the hydrogel was evaluated by measuring the level of TNF-α inflammatory factor. Fig.11 As shown, it can be seen from the data that the level of TNF-α inflammatory factor in the LPS group increased compared with the blank group, indicating that the inflammatory model was successfully constructed. After treatment with the comparison hydrogel 2 and the hydrogel 13 in Example 3, the level of TNF-α inflammatory factor was significantly reduced, indicating that both the glycyrrhizic acid hydrogel alone and the AIE glycyrrhizic acid active hydrogel showed excellent anti-inflammatory ability. It is worth noting that the level of TNF-α inflammatory factor treated with the AIE glycyrrhizic acid active hydrogel was significantly lower than that of the glycyrrhizic acid hydrogel group, indicating that the introduction of berberine derivatives can give the hydrogel a higher anti-inflammatory ability.
[0104] (9) Wound repair experiment of drug-resistant Staphylococcus aureus infection
[0105] A full-thickness circular wound with a diameter of 10 mm was made on the back of 24 6-week-old nude mice using a hole punch and then infected with drug-resistant Staphylococcus aureus (MRSA) (10 8 cfu / mL) and were randomly divided into four groups, with 6 mice in each group. All mice were housed in single cages and each group was treated with PBS, Comparative Example Hydrogel 2, Example 3 Hydrogel 13 and combined with light (20 mW / cm 2 , 10 min) were treated with hydrogel 13 for 11 days, and the wound closure was recorded every other day.
[0106] Fig.12This is a statistical result graph of the change in wound area in the infected skin wound repair experiment after the above treatment. After 11 days of treatment, compared with the wounds treated with PBS and the comparison hydrogel 2, the wounds treated with hydrogel 13, especially the wounds treated with a combination of hydrogel 13 and light (i.e., hydrogel 13-light), showed a smaller wound area and a faster wound healing effect, indicating that the hydrogel prepared by the present invention has a better ability to promote wound healing. Among them, the photodynamic antibacterial ability of AIE glycyrrhizic acid hydrogel can further enhance the role of the hydrogel in promoting the healing of infected wounds, and has great practical application and commercial value in the field of medical materials.
[0107] In summary, the hydrogel dressing prepared by the present invention has excellent aggregation-induced luminescence ability, strong mechanical properties, shear-thinning injectability, high structural recovery ability, temperature / pH-responsive fluorescence properties, significant hydrogel antibacterial and photodynamic synergistic antibacterial ability, and excellent anti-inflammatory ability. It can be used as a new functional AIE hydrogel dressing to promote the healing of infected wounds, and shows potential practical application value in medical gel materials.
[0108] The implementation methods of the present invention are not limited to the above-mentioned embodiments, and any other changes, modifications, substitutions, combinations, and simplifications made without departing from the spirit and principles of the present invention shall be equivalent replacement methods and shall be included in the protection scope of the present invention.
Claims
1. A method for preparing an all-natural aggregation-induced luminescence glycyrrhizic acid active hydrogel, characterized in that: The steps include: (1) Dissolving: Dispersing glycyrrhizic acid or its derivatives uniformly in deionized water, stirring to obtain a transparent solution of glycyrrhizic acid or its derivatives; dispersing a berberine derivative uniformly in deionized water, stirring until the berberine derivative is completely dissolved to obtain a berberine derivative solution; (2) Compounding: adjusting the pH of the glycyrrhizic acid or its derivative solution and the berberine derivative solution obtained in step (1) to neutral with an alkaline pH regulator, and mixing the two at room temperature to obtain a compound solution; (3) Preparation of hydrogel: The composite solution obtained in step (2) is adjusted to acidic pH using an acidic pH regulator under continuous stirring, and stirred until a natural AIE glycyrrhizic acid hydrogel is obtained.
2. The method for preparing a natural aggregation-induced luminescence glycyrrhizic acid active hydrogel according to claim 1, characterized in that: In step (1), the glycyrrhizic acid or its derivatives include one of glycyrrhizic acid, ammonium glycyrrhizinate, ammonium glycyrrhizinate, monopotassium glycyrrhizinate, dipotassium glycyrrhizinate, and trisodium glycyrrhizinate.
3. The method for preparing a natural aggregation-induced luminescence glycyrrhizic acid active hydrogel according to claim 1, characterized in that: In step (1), the berberine derivative includes one of berberine hydrochloride hydrate, berberine chloride hydrate, berberine essence, berberine sulfate hydrate, berberine hydrogen sulfate, and berberine tannate.
4. The method for preparing a natural aggregation-induced luminescence glycyrrhizic acid active hydrogel according to claim 1, characterized in that: In step (1), the stirring temperature is 60-90° C., the stirring speed is 100-500 rpm, and the stirring time is 5-15 min.
5. The method for preparing a natural aggregation-induced luminescence glycyrrhizic acid active hydrogel according to claim 1, characterized in that: In step (1), the concentration of the glycyrrhizic acid or its derivative solution is 2%-6%; the concentration of the berberine derivative solution is 0.5%-2%.
6. The method for preparing a natural aggregation-induced luminescence glycyrrhizic acid active hydrogel according to claim 1, characterized in that: In step (2), the alkaline pH regulator is one of sodium hydroxide solution, potassium hydroxide solution, disodium hydrogen phosphate solution, and sodium bicarbonate; the concentration of the alkaline pH regulator is 0.5-4 mM, and the pH of the glycyrrhizic acid or its derivative solution and the berberine derivative solution is adjusted to 6.0-8.
0.
7. The method for preparing a natural aggregation-induced luminescence glycyrrhizic acid active hydrogel according to claim 1, characterized in that: In step (2), the composite concentration ratio of the glycyrrhizic acid or its derivative solution and the berberine derivative solution is 1000:1-4:1; the concentration of the glycyrrhizic acid or its derivative solution in the composite solution is 0.1%-1%; the concentration of the berberine derivative solution in the composite solution is 0.001%-0.25%.
8. The method for preparing a natural aggregation-induced luminescence glycyrrhizic acid active hydrogel according to claim 1, characterized in that: In step (3), the stirring speed is 400-1000 rpm, and the stirring time is 2-10 min; the acidic pH regulator is one of hydrochloric acid, sulfuric acid, citric acid, tartaric acid, acetic acid, and gluconolactone, and the concentration of the acidic pH regulator is 0.5-2 mM, and the pH of the composite solution is adjusted to 3.0-5.
0.
9. The all-natural aggregation-induced luminescence glycyrrhizic acid active hydrogel prepared by the preparation method according to any one of claims 1 to 8.
10. Use of the all-natural aggregation-induced luminescence glycyrrhizic acid active hydrogel according to claim 9 in drug carriers, antibacterial and anti-inflammatory materials, smart fluorescent materials or medical gel dressings.
Citation Information
Patent Citations
Glycyrrhizic acid-based pH-sensitive slow-release hydrogel material as well as preparation method and application thereof
CN113429589A
Rhein / berberine / glycyrrhizic acid hydrogel as well as preparation method and application thereof
CN116966194A
Preparation method and application of glycyrrhizic acid double-network hydrogel
CN117143360A
cosmetic composition involved Berberin Glycyrrhizinate
KR1020040040787A
